<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31923183</article-id><article-id pub-id-type="pmc">6953834</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0227155</article-id><article-id pub-id-type="publisher-id">PONE-D-19-21966</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Neuroimaging</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Radiology and Imaging</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Tomography</subject><subj-group><subject>Computed Axial Tomography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Tissue Distribution</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Pharmacokinetics</subject><subj-group><subject>Tissue Distribution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Surgical and Invasive Medical Procedures</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Treatment</subject><subj-group><subject>Radiation Therapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Radiation Therapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Radiation Therapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Breast Tumors</subject><subj-group><subject>Breast Cancer</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Treatment</subject><subj-group><subject>Surgical Oncology</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Surgical Oncology</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Surgical Oncology</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Treatment</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Signal Processing</subject><subj-group><subject>Image Processing</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Intraoperative computed tomography imaging for dose calculation in intraoperative electron radiation therapy: Initial clinical observations</article-title><alt-title alt-title-type="running-head">Intraoperative CT imaging for dose calculation in IOERT</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8140-3527</contrib-id><name><surname>Garc&#x000ed;a-V&#x000e1;zquez</surname><given-names>Ver&#x000f3;nica</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Calvo</surname><given-names>Felipe A.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ledesma-Carbayo</surname><given-names>Mar&#x000ed;a J.</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sole</surname><given-names>Claudio V.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Calvo-Haro</surname><given-names>Jos&#x000e9;</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff008"><sup>8</sup></xref><xref ref-type="aff" rid="aff009"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Desco</surname><given-names>Manuel</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff010"><sup>10</sup></xref><xref ref-type="aff" rid="aff011"><sup>11</sup></xref><xref ref-type="aff" rid="aff012"><sup>12</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pascau</surname><given-names>Javier</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff010"><sup>10</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Instituto de Investigaci&#x000f3;n Sanitaria Gregorio Mara&#x000f1;&#x000f3;n, Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Departamento de Oncolog&#x000ed;a, Hospital General Universitario Gregorio Mara&#x000f1;&#x000f3;n, Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Cl&#x000ed;nica Universidad de Navarra, Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Biomedical Image Technologies Laboratory (BIT), Escuela T&#x000e9;cnica Superior de Ingenieros de Telecomunicaci&#x000f3;n, Universidad Polit&#x000e9;cnica de Madrid, Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>CIBER-BBN, Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Department of Radiation Oncology, Instituto de Radiomedicina, Santiago, Regi&#x000f3;n Metropolitana de Santiago, Chile</addr-line></aff><aff id="aff008"><label>8</label>
<addr-line>Servicio de Cirug&#x000ed;a Ortop&#x000e9;dica y Traumatolog&#x000ed;a, Hospital General Universitario Gregorio Mara&#x000f1;&#x000f3;n, Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff009"><label>9</label>
<addr-line>Departamento de Cirug&#x000ed;a, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff010"><label>10</label>
<addr-line>Departamento de Bioingenier&#x000ed;a e Ingenier&#x000ed;a Aeroespacial, Universidad Carlos III de Madrid, Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff011"><label>11</label>
<addr-line>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Salud Mental (CIBERSAM), Madrid, Comunidad de Madrid, Spain</addr-line></aff><aff id="aff012"><label>12</label>
<addr-line>Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Comunidad de Madrid, Spain</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Zhang</surname><given-names>Rongxiao</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Dartmouth College Geisel School of Medicine, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>vgarcia@hggm.es</email> (VGV); <email>jpascau@ing.uc3m.es</email> (JP)</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>15</volume><issue>1</issue><elocation-id>e0227155</elocation-id><history><date date-type="received"><day>4</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Garc&#x000ed;a-V&#x000e1;zquez et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Garc&#x000ed;a-V&#x000e1;zquez et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0227155.pdf"/><abstract><p>In intraoperative electron radiation therapy (IOERT) the energy of the electron beam is selected under the conventional assumption of water-equivalent tissues at the applicator end. However, the treatment field can deviate from the theoretic flat irradiation surface, thus altering dose profiles. This patient-based study explored the feasibility of acquiring intraoperative computed tomography (CT) studies for calculating three-dimensional dose distributions with two factors not included in the conventional assumption, namely the air gap from the applicator end to the irradiation surface and tissue heterogeneity. In addition, dose distributions under the conventional assumption and from preoperative CT studies (both also updated with intraoperative data) were calculated to explore whether there are other alternatives to intraoperative CT studies that can provide similar dose distributions. The IOERT protocol was modified to incorporate the acquisition of intraoperative CT studies before radiation delivery in six patients. Three studies were not valid to calculate dose distributions due to the presence of metal artefacts. For the remaining three cases, the average gamma pass rates between the doses calculated from intraoperative CT studies and those obtained assuming water-equivalent tissues or from preoperative CT studies were 73.4% and 74.0% respectively. The agreement increased when the air gap was included in the conventional assumption (98.1%) or in the preoperative CT images (98.4%). Therefore, this factor was the one mostly influencing the dose distributions of this study. Our experience has shown that intraoperative CT studies are not recommended when the procedure includes the use of shielding discs or surgical retractors unless metal artefacts are removed. IOERT dose distributions calculated under the conventional assumption or from preoperative CT studies may be inaccurate unless the air gap (which depends on the surface irregularities of the irradiated volume and on the applicator pose) is included in the calculations.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades; European Regional Development Fund (ERDF), &#x0201c;A way of making Europe&#x0201d;</institution></funding-source><award-id>TEC2013&#x02013;48251-C2</award-id><principal-award-recipient><name><surname>Pascau</surname><given-names>Javier</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution>Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades; Instituto de Salud Carlos III; European Regional Development Fund (ERDF), &#x0201c;A way of making Europe&#x0201d;</institution></funding-source><award-id>DTS14/00192</award-id><principal-award-recipient><name><surname>Pascau</surname><given-names>Javier</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution>Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades; Instituto de Salud Carlos III; European Regional Development Fund (ERDF), &#x0201c;A way of making Europe&#x0201d;</institution></funding-source><award-id>PI15/02121</award-id><principal-award-recipient><name><surname>Calvo</surname><given-names>Felipe A.</given-names></name></principal-award-recipient></award-group><award-group id="award004"><funding-source><institution>Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades; Instituto de Salud Carlos III; European Regional Development Fund (ERDF), &#x0201c;A way of making Europe&#x0201d;</institution></funding-source><award-id>PI18/01625</award-id><principal-award-recipient><name><surname>Pascau</surname><given-names>Javier</given-names></name></principal-award-recipient></award-group><award-group id="award005"><funding-source><institution>Comunidad de Madrid; European Structural and Investment Fund</institution></funding-source><award-id>TOPUS-CM S2013/MIT3024</award-id></award-group><award-group id="award006"><funding-source><institution>Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades; Pro CNIC Foundation</institution></funding-source></award-group><funding-statement>This study was supported by Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades (<ext-link ext-link-type="uri" xlink:href="http://www.ciencia.gob.es">http://www.ciencia.gob.es</ext-link>) [grant number TEC2013&#x02013;48251-C2 to JP, VG-V and MJL-C], co-funded by European Regional Development Fund (ERDF), &#x0201c;A way of making Europe&#x0201d; (<ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/regional_policy/en/funding/erdf">https://ec.europa.eu/regional_policy/en/funding/erdf</ext-link>); by Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades (<ext-link ext-link-type="uri" xlink:href="http://www.ciencia.gob.es">http://www.ciencia.gob.es</ext-link>), Instituto de Salud Carlos III (<ext-link ext-link-type="uri" xlink:href="https://www.isciii.es">https://www.isciii.es</ext-link>) [grant numbers DTS14/00192 to JP, VG-V and FAC; PI15/02121 to FAC and JC-H; PI18/01625 to JP], co-funded by European Regional Development Fund (ERDF), &#x0201c;A way of making Europe&#x0201d; (<ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/regional_policy/en/funding/erdf">https://ec.europa.eu/regional_policy/en/funding/erdf</ext-link>); and by Comunidad de Madrid (<ext-link ext-link-type="uri" xlink:href="http://www.comunidad.madrid">http://www.comunidad.madrid</ext-link>) [grant number TOPUS-CM S2013/MIT3024 to JP], co-funded by European Structural and Investment Fund (<ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/info/funding-tenders/funding-opportunities/funding-programmes/overview-funding-programmes_en">https://ec.europa.eu/info/funding-tenders/funding-opportunities/funding-programmes/overview-funding-programmes_en</ext-link>). The CNIC is supported by the Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades (<ext-link ext-link-type="uri" xlink:href="http://www.ciencia.gob.es">http://www.ciencia.gob.es</ext-link>) and the Pro CNIC Foundation (<ext-link ext-link-type="uri" xlink:href="https://www.fundacionprocnic.es">https://www.fundacionprocnic.es</ext-link>) [to MD], and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="2"/><page-count count="12"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All exposure data, and the dose distributions, masks and code used in the 3D gamma analyses are available from the Figshare repository (accession number doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.9248897">10.6084/m9.figshare.9248897</ext-link>).</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All exposure data, and the dose distributions, masks and code used in the 3D gamma analyses are available from the Figshare repository (accession number doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.9248897">10.6084/m9.figshare.9248897</ext-link>).</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Intraoperative electron radiation therapy (IOERT) involves the delivery of a single-fraction, high-energy electron beam (4&#x02013;20 MeV) to a post-resection tumour bed, which presents a high probability of harbouring residual cancer cells, or the macroscopic residue after partial resection [<xref rid="pone.0227155.ref001" ref-type="bibr">1</xref>]. The aim of IOERT is to promote local tumour control [<xref rid="pone.0227155.ref002" ref-type="bibr">2</xref>]. A specific applicator docked to a linear accelerator (LINAC) collimates the electron beam towards the treatment field. The risk of irradiating healthy tissues is reduced by displacing or protecting non-involved organs from the radiation beam [<xref rid="pone.0227155.ref003" ref-type="bibr">3</xref>].</p><p>In IOERT procedures, radiation oncologists choose treatment parameters according to intraoperative conditions and clinical experience. These include applicator diameter, bevel angle, applicator pose (application position and angle of beam incidence) in relation to the patient&#x000b4;s anatomy and prescribed dose at a specific depth. This information is transmitted to medical physicists, who select an appropriate energy of the electron beam so that a specific percentage isodose contour (commonly 90%), at which the dose is prescribed, encompasses the target volume. The beam energy is selected based on dose profiles measured in water phantoms for different energies and applicator parameters since the conventional assumption in IOERT is a flat irradiation surface with water-equivalent tissues in both stopping and scattering power at the applicator end.</p><p>A further step in IOERT dose calculation involves the use of a specific commercial treatment planning system (TPS) [<xref rid="pone.0227155.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0227155.ref005" ref-type="bibr">5</xref>] or other solutions developed for this purpose [<xref rid="pone.0227155.ref006" ref-type="bibr">6</xref>] that take account of tissue heterogeneity by means of computed tomography (CT) studies. However, the actual treatment field can deviate from that foreseen in the TPS when using preoperative CT studies owing to variations in the patient&#x02019;s position, surgical access, tumour resection and IOERT parameters. In addition, postresected surface irregularities can significantly affect the IOERT dose distribution. Costa et al [<xref rid="pone.0227155.ref007" ref-type="bibr">7</xref>] simulated characteristic pelvic IOERT scenarios with solid water slabs and a radiotherapy bolus, finding that a curved irradiation surface caused the two-dimensional dose distribution (measured with radiochromic films) to be curved and deeper than that with a flat irradiation surface.</p><p>Intraoperative three-dimensional (3D) images are not regularly acquired so accurate reconstruction of the irradiated volume is not available. This information is relevant to the proper assessment of clinical results [<xref rid="pone.0227155.ref008" ref-type="bibr">8</xref>]. Underdosage or overdosage of target volumes and organs at risk may lead to inappropriate rates of local recurrence or adverse effects. Trifiletti et al [<xref rid="pone.0227155.ref009" ref-type="bibr">9</xref>] pointed out several limitations of intraoperative radiation therapy in breast cancer, including the lack of intraoperative imaging to calculate customised 3D dose distributions before radiation delivery. In a preliminary experience presented at ASTRO [<xref rid="pone.0227155.ref010" ref-type="bibr">10</xref>], our group evaluated the difference between the 3D dose distributions when calculated from preoperative and intraoperative CT images. It was necessary to apply several preprocessing steps to preoperative images (namely virtual removal of the tumour and its surrounding tissues as performed during surgery, plus deformable registration to align preoperative and intraoperative studies) to obtain an average difference in dose of 5%. Dose distributions were calculated with Pencil Beam algorithm (method with known limitations [<xref rid="pone.0227155.ref005" ref-type="bibr">5</xref>]). In addition, that evaluation did not consider the distance-to-agreement concept included in the gamma index [<xref rid="pone.0227155.ref011" ref-type="bibr">11</xref>], which is the mainstay of comparisons between dose distributions in medical physics.</p><p>This patient-based study explored the feasibility of acquiring intraoperative CT studies for calculating IOERT 3D dose distributions, estimated with a Monte Carlo method [<xref rid="pone.0227155.ref012" ref-type="bibr">12</xref>], with two factors not included in the conventional assumption, namely the air gap from the applicator end to the irradiation surface (which depends on the surface irregularities of the irradiated volume and on the applicator pose) and tissue heterogeneity. This article extended the number of cases and disease sites presented in our initial report [<xref rid="pone.0227155.ref010" ref-type="bibr">10</xref>]. In addition, dose distributions under the conventional assumption of water-equivalent tissues at the applicator end and from preoperative CT studies (both also updated with intraoperative data) were calculated to explore whether there are other alternatives to intraoperative CT studies that can provide similar dose distributions. To our knowledge, no previous studies have pursued these objectives.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><p>In this section, we describe the cases evaluated in this study (subsection &#x0201c;Cases&#x0201d;), the protocol followed to acquire the preoperative and intraoperative CT images (subsection &#x0201c;Protocol&#x0201d;), the processing steps applied to the images (subsection &#x0201c;Image processing&#x0201d;), the calculation of the IOERT dose distributions, and the methodology for the dose comparison (subsection &#x0201c;IOERT dose distributions&#x0201d;).</p><sec id="sec003"><title>Cases</title><p>Six patients undergoing IOERT were enrolled for this study after giving informed consent. The study was conducted in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) and was approved by the Ethics Committee at Hospital General Universitario Gregorio Mara&#x000f1;&#x000f3;n. The diagnosis of each patient and the IOERT parameters are detailed in <xref rid="pone.0227155.t001" ref-type="table">Table 1</xref>. In both breast cancer cases, a shielding disc made of lead (diameter of 6 cm and thickness 3 mm) was used to protect intrathoracic organs during irradiation. Surgical retractors made of stainless steel were used in the retroperitoneal sarcoma case.</p><table-wrap id="pone.0227155.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227155.t001</object-id><label>Table 1</label><caption><title>IOERT data and CT acquisition parameters.</title></caption><alternatives><graphic id="pone.0227155.t001g" xlink:href="pone.0227155.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1"/><th align="center" colspan="4" rowspan="2">IOERT DATA</th><th align="center" colspan="3" rowspan="1">CT ACQUISITION PARAMETERS</th></tr><tr><th align="center" colspan="3" rowspan="1">(In all acquisitions, voltage 120 kVp)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Applicator diameter (cm)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Bevel angle</bold></td><td align="center" rowspan="1" colspan="1"><bold>Energy (MeV)</bold></td><td align="center" rowspan="1" colspan="1"><bold>90% isodose (Gy)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Exposure (mAs)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Voxel size (mm)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Days between CT studies</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Patient 1</bold></td><td align="center" rowspan="2" colspan="1">8</td><td align="center" rowspan="2" colspan="1">15&#x000b0;</td><td align="center" rowspan="2" colspan="1">6</td><td align="center" rowspan="2" colspan="1">10</td><td align="center" rowspan="1" colspan="1">35 &#x000b1; 7<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref><xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">1.3 x 1.3 x 5.0<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="2" colspan="1">6</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>(Ewing sarcoma)</bold></td><td align="center" rowspan="1" colspan="1">125<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">1.3 x 1.3 x 2.0<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Patient 2</bold></td><td align="center" rowspan="2" colspan="1">12</td><td align="center" rowspan="2" colspan="1">30&#x000b0;</td><td align="center" rowspan="2" colspan="1">8</td><td align="center" rowspan="2" colspan="1">12.5</td><td align="center" rowspan="2" colspan="1">125</td><td align="center" rowspan="1" colspan="1">1.1 x 1.1 x 2.0<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="2" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>(Rhabdomyosarcoma)</bold></td><td align="center" rowspan="1" colspan="1">1.6 x 1.6 x 2.0<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Patient 3</bold></td><td align="center" rowspan="2" colspan="1">5</td><td align="center" rowspan="2" colspan="1">30&#x000b0;</td><td align="center" rowspan="2" colspan="1">6</td><td align="center" rowspan="2" colspan="1">10</td><td align="center" rowspan="1" colspan="1">100<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">0.6 x 0.6 x 1.6<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="2" colspan="1">17</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>(Breast cancer, right)</bold></td><td align="center" rowspan="1" colspan="1">127 &#x000b1; 66<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref><xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">1.3 x 1.3 x 3.0<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Patient 4</bold></td><td align="center" rowspan="2" colspan="1">5</td><td align="center" rowspan="2" colspan="1">0&#x000b0;</td><td align="center" rowspan="2" colspan="1">6</td><td align="center" rowspan="2" colspan="1">10</td><td align="center" rowspan="1" colspan="1">100<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">0.7 x 0.7 x 1.6<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="2" colspan="1">9</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>(Breast cancer, left)</bold></td><td align="center" rowspan="1" colspan="1">114 &#x000b1; 27<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref><xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">1.1 x 1.1 x 5.0<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Patient 5</bold></td><td align="center" rowspan="2" colspan="1">10</td><td align="center" rowspan="2" colspan="1">30&#x000b0;</td><td align="center" rowspan="2" colspan="1">8</td><td align="center" rowspan="2" colspan="1">12.5</td><td align="center" rowspan="1" colspan="1">196 &#x000b1; 22<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref><xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">0.7 x 0.7 x 1.0<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="2" colspan="1">1</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>(Retroperitoneal sarcoma)</bold></td><td align="center" rowspan="1" colspan="1">217 &#x000b1; 7<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref><xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">1.4 x 1.4 x 2.0<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Patient 6</bold></td><td align="center" rowspan="2" colspan="1">7</td><td align="center" rowspan="2" colspan="1">30&#x000b0;</td><td align="center" rowspan="2" colspan="1">9</td><td align="center" rowspan="2" colspan="1">12.5</td><td align="center" rowspan="1" colspan="1">132 &#x000b1; 62<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref><xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">1.2 x 1.2 x 2.0<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="2" colspan="1">0</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>(Chondrosarcoma)</bold></td><td align="center" rowspan="1" colspan="1">143 &#x000b1; 54<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref><xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">0.9 x 0.9 x 2.0<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><sup>a</sup>Mean &#x000b1; standard deviation.</p></fn><fn id="t001fn002"><p><sup>b</sup>Preoperative CT image.</p></fn><fn id="t001fn003"><p><sup>c</sup>Intraoperative CT image.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec004"><title>Protocol</title><p>Preoperative CT images were acquired on a Toshiba Aquilion&#x02122; Large Bore CT simulator (Patients 1, 2 and 6), a Philips Mx8000 CT (Patients 3 and 4), and a Philips Brilliance-16 CT (Patient 5).</p><p>The conventional IOERT protocol included the patient transfer from the operating room (OR) to the treatment room for irradiation. This transfer was necessary, since a dedicated mobile LINAC was not available inside the OR. The IOERT protocol was modified to incorporate the acquisition of the intraoperative CT study of the actual scenario as follows:
<list list-type="order"><list-item><p>The patient lay on a rigid radiotransparent subtable that was placed on the operating table during surgery.</p></list-item><list-item><p>After tumour resection, the IOERT applicator was placed over the tumour bed and firmly attached to the radiotransparent subtable with an articulated arm.</p></list-item><list-item><p>The patient was covered to maintain asepsis of the surgical field during transfer to the CT simulator room and treatment room. A subtable stretcher, similar to that presented in [<xref rid="pone.0227155.ref013" ref-type="bibr">13</xref>], made it possible to carry the subtable from the operating table to the CT/LINAC table. The radiotransparent subtable and the subtable stretcher were custom-made for this study.</p></list-item><list-item><p>An intraoperative CT image of the whole setting (applicator placed on the treatment field) was acquired on a Toshiba Aquilion&#x02122; Large Bore CT simulator.</p></list-item></list></p><p>After these steps, the conventional protocol was followed: the patient was transferred to the treatment room for irradiation with a fixed LINAC (Elekta Precise Treatment System&#x02122;) and then back to the OR to complete the surgical procedure. This protocol did not include in vivo dosimetry. Patients were monitored under general anaesthesia throughout the IOERT procedure. No IOERT decisions were taken based on the intraoperative images. <xref rid="pone.0227155.t001" ref-type="table">Table 1</xref> shows CT acquisition parameters of preoperative and intraoperative images, and the time interval between both studies.</p></sec><sec id="sec005"><title>Image processing</title><sec id="sec006"><title>Image registration</title><p>Preoperative CT images were rigidly registered to their corresponding intraoperative CT studies to calculate dose distributions in the same coordinate space and with the same applicator pose in relation to the patient&#x02019;s anatomy. This image processing was done by carrying out the following steps with MMWKS software [<xref rid="pone.0227155.ref014" ref-type="bibr">14</xref>]. First, CT images were resampled to 1.5-mm isotropic voxel size, and bone structures close to the treatment volume were segmented using a region-growing method [<xref rid="pone.0227155.ref015" ref-type="bibr">15</xref>] plus manually delineated boundaries. After this, preoperative images were aligned with their corresponding intraoperative images by using an automatic rigid registration algorithm based on normalised mutual information as a cost function [<xref rid="pone.0227155.ref016" ref-type="bibr">16</xref>], calculated only in the segmented bones.</p></sec><sec id="sec007"><title>Air gap segmentation</title><p>With respect to dose calculation, an important difference between preoperative and intraoperative CT images is related to the potential air gap from the applicator end to the irradiation surface (which depends on the surface irregularities of the tumour bed and on the applicator pose). This feature was obtained from the intraoperative CT images by segmenting the air gap along the longitudinal extension of the applicator using a region-growing method (maximum limit &#x02013;500 Hounsfield units, HU) plus manually delineated boundaries. The air gap was included in the registered preoperative CT images by setting the corresponding segmented voxels to air value (&#x02013;1000 HU). For each IOERT case, another image was created to take account of the air gap but not the tissue heterogeneities in dose comparisons by also setting the remaining voxels of each modified registered preoperative image to the water value (0 HU).</p></sec><sec id="sec008"><title>Identification of the applicator pose</title><p>The following semiautomatic method was used to obtain the applicator pose (position of the bevel centre and rotation of the applicator) in each intraoperative image since the CT values of the applicator, which was made of polymethyl methacrylate, are similar to those of soft tissues. First, a segmentation of the applicator wall with a region-growing method plus manually delineated boundaries was used to calculate the X and Y coordinates of the bevel centre and the geometric axis of the applicator. After this, the end of the shorter edge of the applicator was manually located at an axial slice, enabling us to find the remaining parameters of the applicator pose.</p></sec></sec><sec id="sec009"><title>IOERT dose distributions</title><p>IOERT cases were simulated using <italic>radiance</italic> TPS (GMV, Spain) [<xref rid="pone.0227155.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0227155.ref005" ref-type="bibr">5</xref>], the registered preoperative and intraoperative images of each patient, and the IOERT parameters shown in <xref rid="pone.0227155.t001" ref-type="table">Table 1</xref>. The parameters obtained in subsection &#x0201c;Identification of the application pose&#x0201d; were used to match the pose of the virtual applicator in the TPS to that depicted in each intraoperative image. The TPS automatically modified the CT value of the voxels inside the applicator, setting them to the air value.</p><p>Dose distributions were calculated based on a Monte Carlo algorithm specifically adapted for IOERT [<xref rid="pone.0227155.ref012" ref-type="bibr">12</xref>] (uncertainty 1%, resolution 1.5 mm), the phase space of the LINAC [<xref rid="pone.0227155.ref017" ref-type="bibr">17</xref>], and the registered preoperative and intraoperative images of each patient after converting HU values to physical density [<xref rid="pone.0227155.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0227155.ref018" ref-type="bibr">18</xref>] as follows:
<list list-type="bullet"><list-item><p>D_intraCT, considered the gold standard as this dose distribution was calculated from each intraoperative study, which showed the actual IOERT scenario before irradiation (namely, after tumour removal and with the applicator in place).</p></list-item><list-item><p>D_preCT<sub>water</sub>, dose distribution calculated from each registered preoperative image by selecting the <italic>Water</italic> option in the TPS to assume water-equivalent tissues at the applicator end (conventional assumption).</p></list-item><list-item><p>D_preCT, dose distribution calculated from each registered preoperative image, thus including tissue heterogeneities but not the air gap at the applicator end.</p></list-item><list-item><p>D_preCT<sub>water&#x00026;air</sub>, dose distribution calculated from each registered preoperative image assuming water-equivalent tissues and including the air gap at the applicator end (as detailed in subsection &#x0201c;Air gap segmentation&#x0201d;).</p></list-item><list-item><p>D_preCT<sub>air</sub>, dose distribution calculated from each registered preoperative image (thus taking into account tissue heterogeneities) and including the air gap at the applicator end (as detailed in subsection &#x0201c;Air gap segmentation&#x0201d;).</p></list-item></list></p><p>D_PreCT<sub>water</sub>, D_preCT, D_preCT<sub>water&#x00026;air</sub> and D_preCT<sub>air</sub> were compared with the corresponding D_intraCT using a 3D gamma criteria of 3%/3 mm for dose values greater than 10% or 70% (to focus on high-dose regions) [<xref rid="pone.0227155.ref018" ref-type="bibr">18</xref>], and global normalisation [<xref rid="pone.0227155.ref019" ref-type="bibr">19</xref>]. These comparisons were intended to identify the relative contribution in dose calculation of tissue heterogeneity and air gap (which depended on the surface irregularities of the tumour bed and on the applicator pose) in order to explore whether there are other alternatives to intraoperative CT studies. Voxels not belonging to patient tissue in each D_intraCT were not taken into account in the 3D gamma analyses.</p></sec></sec><sec sec-type="results" id="sec010"><title>Results</title><p>The six patients in this study underwent IOERT following the protocol described. There were no complications for the patients during transfer, which was performed using the subtable and its stretcher, or during the acquisition of intraoperative CT images (anaesthetic instability or any other relevant clinical observations). This protocol was applied by a coordinated multidisciplinary team that was accustomed to performing the conventional protocol, which involved transferring the anaesthetised patient from the OR to the treatment room for irradiation.</p><p>Dose distributions were not calculated in three cases (Patients 3, 4, and 5) owing to artefacts (severe streaking) in the intraoperative images caused by metallic objects (shielding discs in the breast cancer cases and surgical retractors in the retroperitoneal sarcoma case), which substantially modified the CT values (<xref ref-type="fig" rid="pone.0227155.g001">Fig 1</xref>). These intraoperative images were not appropriate to calculate gold standards for dose comparisons. In both breast cancer cases (<xref ref-type="fig" rid="pone.0227155.g001">Fig 1A and 1B</xref>), there were dark streaks along the radial axis of the shielding discs and bright streaks along its perpendicular axis. These artefacts were larger than the dimensions of the shielding disc. In the case of Patient 3, the applicator was not sufficiently firmly attached and moved during the transfer to the CT room. This attachment problem was detected at the treatment room where the applicator pose was corrected before irradiation. The intraoperative image showed that the shielding disc was not aligned with the applicator (<xref ref-type="fig" rid="pone.0227155.g001">Fig 1A</xref>).</p><fig id="pone.0227155.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227155.g001</object-id><label>Fig 1</label><caption><title>Intraoperative images with metal artefacts.</title><p>Volume rendering view (top) and axial view (bottom). (A) Patient 3 (breast cancer, right). (B) Patient 4 (breast cancer, left). (C) Patient 5 (retroperitoneal sarcoma).</p></caption><graphic xlink:href="pone.0227155.g001"/></fig><p>Registration between the preoperative and intraoperative CT studies (specifically the bone structures close to the treatment volume) was checked by visual inspection. As expected, the alignment of structures far from the treatment volume was not perfect owing to the rigid transformation used for registration but inside the treatment volume it was correct. The root-mean-square difference between both images and considering just voxels belonging to patient tissue was 88 HU (Patient 1), 95 HU (Patient 2) and 113 HU (Patient 6). The volumes of interest of these measurements were limited to those of the 3D dose distributions (<xref rid="pone.0227155.t002" ref-type="table">Table 2</xref>). Voxels not belonging to patient tissue in each D_intraCT were not taken into account as set in the 3D gamma analyses. The maximum distances from the applicator end to the surface of the tumour bed were 14.5 mm (Patient 1), 8.5 mm (Patient 2) and 30.5 mm (Patient 6). Dose distributions are shown in <xref ref-type="fig" rid="pone.0227155.g002">Fig 2</xref> (Patients 1, 2 and 6). The average gamma pass rates were 73.4% and 74.0% for D_preCT<sub>water</sub> and D_preCT respectively (<xref rid="pone.0227155.t002" ref-type="table">Table 2</xref>). Better results were found when the air gap was included in the IOERT dose calculation (98.1% and 98.4% for D_preCT<sub>water&#x00026;air</sub> and D_preCT<sub>air</sub> respectively).</p><fig id="pone.0227155.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227155.g002</object-id><label>Fig 2</label><caption><title>Dose distributions calculated using the Monte Carlo algorithm.</title><p>(A) Patient 1 (Ewing sarcoma, coronal view). (B) Patient 2 (rhabdomyosarcoma, sagittal view). (C) Patient 6 (chondrosarcoma, axial view). H (head), F (feet), A (anterior), P (posterior), R (right) and L (left).</p></caption><graphic xlink:href="pone.0227155.g002"/></fig><table-wrap id="pone.0227155.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227155.t002</object-id><label>Table 2</label><caption><title>Percentage of voxels fulfilling 3D gamma criteria of 3%/3 mm.</title><p>Gamma pass rates &#x02265; 95% highlighted in bold.</p></caption><alternatives><graphic id="pone.0227155.t002g" xlink:href="pone.0227155.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Dose &#x0003e; 10%</th><th align="center" rowspan="1" colspan="1">Dose &#x0003e; 70%</th></tr></thead><tbody><tr><td align="center" rowspan="2" colspan="1"><bold>Patient 1</bold></td><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT<sub>water</sub></td><td align="center" rowspan="1" colspan="1">81.9</td><td align="center" rowspan="1" colspan="1">81.5</td></tr><tr><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT</td><td align="center" rowspan="1" colspan="1">81.8</td><td align="center" rowspan="1" colspan="1">81.6</td></tr><tr><td align="center" rowspan="2" colspan="1"><bold>(Ewing sarcoma)</bold></td><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT<sub>water&#x00026;air</sub></td><td align="center" rowspan="1" colspan="1"><bold>99.8</bold></td><td align="center" rowspan="1" colspan="1"><bold>99.9</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT<sub>air</sub></td><td align="center" rowspan="1" colspan="1"><bold>99.5</bold></td><td align="center" rowspan="1" colspan="1"><bold>99.8</bold></td></tr><tr><td align="center" rowspan="2" colspan="1"><bold>Patient 2</bold></td><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT<sub>water</sub><xref ref-type="table-fn" rid="t002fn003"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">90.0</td><td align="center" rowspan="1" colspan="1">92.1</td></tr><tr><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT</td><td align="center" rowspan="1" colspan="1">92.3</td><td align="center" rowspan="1" colspan="1">92.2</td></tr><tr><td align="center" rowspan="2" colspan="1"><bold>(Rhabdomyosarcoma)</bold></td><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT<sub>water&#x00026;air</sub></td><td align="center" rowspan="1" colspan="1"><bold>97.3</bold></td><td align="center" rowspan="1" colspan="1"><bold>99.3</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT<sub>air</sub></td><td align="center" rowspan="1" colspan="1"><bold>99.6</bold></td><td align="center" rowspan="1" colspan="1"><bold>99.4</bold></td></tr><tr><td align="center" rowspan="2" colspan="1"><bold>Patient 6</bold></td><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT<sub>water</sub><xref ref-type="table-fn" rid="t002fn004"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">52.6</td><td align="center" rowspan="1" colspan="1">42.0</td></tr><tr><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT</td><td align="center" rowspan="1" colspan="1">53.6</td><td align="center" rowspan="1" colspan="1">42.5</td></tr><tr><td align="center" rowspan="2" colspan="1"><bold>(Chondrosarcoma)</bold></td><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT<sub>water&#x00026;air</sub></td><td align="center" rowspan="1" colspan="1"><bold>95.0</bold></td><td align="center" rowspan="1" colspan="1"><bold>97.5</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">D_intraCT v D_preCT<sub>air</sub></td><td align="center" rowspan="1" colspan="1">94.5</td><td align="center" rowspan="1" colspan="1"><bold>97.8</bold></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Dose matrices: 183 x 235 x 175, 180 x 156 x 256 and 200 x 179 x 250 for Patient 1, Patient 2 and Patient 6 respectively. Voxel size 1.5 x 1.5 x 1.5 mm.</p></fn><fn id="t002fn002"><p>Average gamma pass rates: 73.4%, 74.0%, <bold>98.1</bold>% and <bold>98.4</bold>% for D_preCT<sub>water</sub>, D_preCT, D_preCT<sub>water&#x00026;air</sub> and D_preCT<sub>air</sub> respectively.</p></fn><fn id="t002fn003"><p><sup>a</sup>Average gamma pass rate: 91.1%.</p></fn><fn id="t002fn004"><p><sup>b</sup>Average gamma pass rate: 47.3%.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="conclusions" id="sec011"><title>Discussion</title><p>This is the first patient-based study that explores the feasibility of acquiring intraoperative CT studies for calculating IOERT 3D dose distributions, apart from our initial report presented at ASTRO [<xref rid="pone.0227155.ref010" ref-type="bibr">10</xref>]. There were no complications for the patients during the modified IOERT protocol that incorporated the acquisition of the actual scenario before irradiation. These images also allow inspection of the protection assembly (<xref ref-type="fig" rid="pone.0227155.g001">Fig 1A and 1B</xref>), which is the major source of problems in IOERT [<xref rid="pone.0227155.ref020" ref-type="bibr">20</xref>] because of the lack of direct visual inspection of the shielding disc. However, standard clinical practice cannot include the use of a CT simulator for intraoperative imaging in IOERT. Transferring the patient to the CT simulator room involves additional risks for the patient and may not be indicated when a dedicated mobile LINAC is available inside the OR. Other possible ways to acquire these intraoperative images for calculating IOERT 3D dose distributions are a portable CT inside the OR, or even a LINAC that includes on-board kV cone beam CT [<xref rid="pone.0227155.ref018" ref-type="bibr">18</xref>]. However, a low number of treatments per week may not justify the installation costs of in-room imaging [<xref rid="pone.0227155.ref021" ref-type="bibr">21</xref>].</p><p>Intraoperative CT imaging in IOERT procedures allows the calculation of 3D dose distributions with two factors not included in the conventional assumption, namely the air gap from the applicator end to the irradiation surface (which depends on the surface irregularities of the irradiated volume and on the applicator pose) and tissue heterogeneity. The main limitation of these intraoperative images for dose calculation is the presence of metal artefacts in some IOERT scenarios, owing to shielding discs and surgical retractors. A two-layered disc such as the one described in [<xref rid="pone.0227155.ref022" ref-type="bibr">22</xref>] would decrease, but not remove, the metal artefacts, since copper has a lower attenuation coefficient than lead. In the case of the retractors, a possible approach would be to use a nonmetallic version, although this is not common in clinical practice. The solution presented in [<xref rid="pone.0227155.ref023" ref-type="bibr">23</xref>] was a 3D-printed thermoplastic Army/Navy retractor. An alternative would be to replace incorrect CT values with the corresponding ones from the registered preoperative image or to include a metal artefact reduction algorithm in CT reconstruction [<xref rid="pone.0227155.ref024" ref-type="bibr">24</xref>], although this would require further research on assessing the accuracy of the IOERT dose distributions after applying those corrections.</p><p>Surface irregularities influenced doses, as displayed in the 3D dose distributions obtained from the intraoperative images (<xref ref-type="fig" rid="pone.0227155.g002">Fig 2A and 2C</xref>). These results were expected given the findings from previous studies [<xref rid="pone.0227155.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0227155.ref025" ref-type="bibr">25</xref>] (phantom study and in vivo study, respectively), where two-dimensional dose distributions were obtained from radiochromic films placed on the irradiation surface. In [<xref rid="pone.0227155.ref025" ref-type="bibr">25</xref>], the authors showed that measured doses frequently differ from the expected ones in IOERT of rectal cancer (scenario that often presents surface irregularities). The approach used in our study was to calculate 3D dose distributions of the actual IOERT scenario before irradiation, instead of measuring a partial view of the dose distribution with radiochromic films, showing interesting spatial details about the dose distribution. For instance, D_intraCT corresponding to Patient 6 (<xref ref-type="fig" rid="pone.0227155.g002">Fig 2C</xref>) presented a hot spot probably due to the scatter produced by the sharp irregularities on the irradiated surface [<xref rid="pone.0227155.ref026" ref-type="bibr">26</xref>], and a flat irradiation surface probably related to the accumulation of biological fluid in that region, which affects the dose distribution (build-up effect) [<xref rid="pone.0227155.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0227155.ref027" ref-type="bibr">27</xref>]. On the other hand, the implemented Monte Carlo algorithm has some limitations since it does not take account of tissue bulging into the applicator opening, as shown in <xref ref-type="fig" rid="pone.0227155.g002">Fig 2</xref>.</p><p>Despite the reduced number of patients in our study, three different situations in terms of dose agreement were found, ranging from one where assuming water-equivalent tissues was almost valid (Patient 2) to other where the conventional assumption provided inaccurate dose distributions (Patient 6). In the evaluated IOERT scenarios, the greater the maximum distance from the applicator end to the surface of the tumour bed (air gap), the larger the difference in gamma criteria between D_preCT<sub>water</sub> and D_intraCT. The best case corresponded to Patient 2 (maximum distance of 8.5 mm and an average gamma pass rate of 91.1%) while the worst case corresponded to Patient 6 (maximum distance of 30.5 mm and an average gamma pass rate of 47.3%).</p><p>Registered preoperative images did not improve the calculation of dose distribution (D_preCT, average gamma pass rate of 74.0%) compared with the usual IOERT simplification (D_preCT<sub>water</sub>, average of 73.4%), even though those images included tissue heterogeneities and the information regarding the applicator pose in relation to the patient&#x02019;s anatomy. A better dose agreement was found when the air gap was included in the conventional assumption (D_preCT<sub>water&#x00026;air</sub>, average of 98.1%) or in the preoperative images (D_preCT<sub>air</sub>, average of 98.4%, approach that takes into account of tissue heterogeneity). Therefore, the air gap was the factor mostly influencing the dose distributions of this study with a different impact depending on the IOERT case (namely, less impact in Patient 2 than in Patient 6). Previous studies have reported different scenarios regarding the air gap: lengths up to 5 cm in soft-tissue sarcomas of distal limbs [<xref rid="pone.0227155.ref028" ref-type="bibr">28</xref>], irregular and/or concave surfaces in rectal cancer [<xref rid="pone.0227155.ref025" ref-type="bibr">25</xref>], and soft breast tissue adapted to the flat end of a non-bevelled applicator [<xref rid="pone.0227155.ref007" ref-type="bibr">7</xref>]. Therefore, air gap should be included in IOERT records to assess whether the conventional assumption is valid in each treatment. Finally, tissue heterogeneity was not a key factor in the cases evaluated since bones were at a certain distance from the tumour bed, but it would be the case in rectal cancer since the tumour bed or high-risk area is very close to the sacrum.</p><p>The acquisition of the actual IOERT scenario before irradiation, specifically the surface irregularities of the tumour bed and the applicator pose, is relevant to record the treatment administered to the patient. Surface scanning of the irradiated volume combined with the applicator pose and assuming water-equivalent tissues from the irradiation surface, as proposed in [<xref rid="pone.0227155.ref029" ref-type="bibr">29</xref>], might be an alternative to explore in the future. Nevertheless, including this approach in the IOERT workflow entails first addressing some practical problems. Further research on improving the accuracy of the IOERT dose calculation is commended since these dose distributions would allow assessment of the treatment outcome and calculation of dose accumulation when external beam radiation therapy is applied with an IOERT boost component.</p></sec><sec sec-type="conclusions" id="sec012"><title>Conclusions</title><p>Intraoperative CT studies for calculating 3D dose distributions were acquired in several IOERT scenarios with no complications for the patients. Our experience has shown that intraoperative CT studies are not recommended when the procedure includes the use of shielding discs or surgical retractors unless metal artefacts are removed. Air gap and not tissue heterogeneity was the factor mostly influencing the evaluated dose distributions. The conventional assumption of water-equivalent tissues at the applicator end or the use of preoperative CT studies may lead to inaccurate IOERT dose distributions unless the air gap from the applicator end to the irradiation surface (which depends on the surface irregularities of the irradiated volume and on the applicator pose) is included in the calculations.</p></sec></body><back><ack><p>The authors extend their gratitude to GMV SA (Madrid, Spain), Paula Ib&#x000e1;&#x000f1;ez, Jos&#x000e9; Manuel Udias (Grupo de F&#x000ed;sica Nuclear, Universidad Complutense de Madrid, Madrid, Spain), Professor Juan Antonio Santos-Miranda, Dr Carmen Gonz&#x000e1;lez-San-Segundo (Hospital General Universitario Gregorio Mara&#x000f1;&#x000f3;n, Madrid, Spain), medical physicists and radiotherapy technicians at Hospital General Universitario Gregorio Mara&#x000f1;&#x000f3;n, and Juan L&#x000f3;pez-Tarjuelo (Consorcio Hospitalario Provincial de Castell&#x000f3;n, Castell&#x000f3;n de la Plana, Spain) for their valuable technical and clinical support.</p></ack><ref-list><title>References</title><ref id="pone.0227155.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Calvo</surname><given-names>FA</given-names></name>, <name><surname>Meirino</surname><given-names>RM</given-names></name>, <name><surname>Orecchia</surname><given-names>R</given-names></name>. <article-title>Intraoperative radiation therapy. First part: rationale and techniques</article-title>. <source>Crit Rev Oncol Hematol</source>. <year>2006</year>;<volume>59</volume>: <fpage>106</fpage>&#x02013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.critrevonc.2005.11.004</pub-id>
<pub-id pub-id-type="pmid">16844383</pub-id></mixed-citation></ref><ref id="pone.0227155.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Calvo</surname><given-names>FA</given-names></name>. <article-title>Intraoperative irradiation: precision medicine for quality cancer control promotion</article-title>. <source>Radiat Oncol</source>. <year>2017</year>;<volume>12</volume>: <fpage>36</fpage>
<pub-id pub-id-type="doi">10.1186/s13014-017-0764-5</pub-id>
<pub-id pub-id-type="pmid">28148287</pub-id></mixed-citation></ref><ref id="pone.0227155.ref003"><label>3</label><mixed-citation publication-type="book"><name><surname>Gunderson</surname><given-names>LL</given-names></name>, <name><surname>Calvo</surname><given-names>FA</given-names></name>, <name><surname>Willett</surname><given-names>CG</given-names></name>, <name><surname>Harrison</surname><given-names>LB</given-names></name>. <chapter-title>Rationale and historical perspective of intraoperative irradiation</chapter-title> In: <name><surname>Gunderson</surname><given-names>LL</given-names></name>, <name><surname>Willett</surname><given-names>CG</given-names></name>, <name><surname>Calvo</surname><given-names>FA</given-names></name>, <name><surname>Harrison</surname><given-names>LB</given-names></name>, editors. <source>Intraoperative irradiation: techniques and results</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Humana Press</publisher-name>; <year>2011</year> pp. <fpage>3</fpage>&#x02013;<lpage>26</lpage>.</mixed-citation></ref><ref id="pone.0227155.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Pascau</surname><given-names>J</given-names></name>, <name><surname>Santos Miranda</surname><given-names>JA</given-names></name>, <name><surname>Calvo</surname><given-names>FA</given-names></name>, <name><surname>Bouch&#x000e9;</surname><given-names>A</given-names></name>, <name><surname>Morillo</surname><given-names>V</given-names></name>, <name><surname>Gonz&#x000e1;lez-San Segundo</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>An innovative tool for intraoperative electron beam radiotherapy simulation and planning: description and initial evaluation by radiation oncologists</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2012</year>;<volume>83</volume>: <fpage>e287</fpage>&#x02013;<lpage>e295</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijrobp.2011.12.063</pub-id>
<pub-id pub-id-type="pmid">22401923</pub-id></mixed-citation></ref><ref id="pone.0227155.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Valdivieso-Casique</surname><given-names>MF</given-names></name>, <name><surname>Rodr&#x000ed;guez</surname><given-names>R</given-names></name>, <name><surname>Rodr&#x000ed;guez-Besc&#x000f3;s</surname><given-names>S</given-names></name>, <name><surname>Lard&#x000ed;es</surname><given-names>D</given-names></name>, <name><surname>Guerra</surname><given-names>P</given-names></name>, <name><surname>Ledesma</surname><given-names>MJ</given-names></name>, <etal>et al</etal>
<article-title>RADIANCE&#x02013;A planning software for intra-operative radiation therapy</article-title>. <source>Transl Cancer Res</source>. <year>2015</year>;<volume>4</volume>: <fpage>196</fpage>&#x02013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.3978/j.issn.2218-676X.2015.04.05</pub-id></mixed-citation></ref><ref id="pone.0227155.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Alhamada</surname><given-names>H</given-names></name>, <name><surname>Simon</surname><given-names>S</given-names></name>, <name><surname>Philippson</surname><given-names>C</given-names></name>, <name><surname>Vandekerkhove</surname><given-names>C</given-names></name>, <name><surname>Jourani</surname><given-names>Y</given-names></name>, <name><surname>Pauly</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>3D Monte Carlo dosimetry of intraoperative electron radiation therapy (IOERT)</article-title>. <source>Phys Med</source>. <year>2019</year>;<volume>57</volume>: <fpage>207</fpage>&#x02013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmp.2018.12.037</pub-id>
<pub-id pub-id-type="pmid">30738527</pub-id></mixed-citation></ref><ref id="pone.0227155.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Costa</surname><given-names>F</given-names></name>, <name><surname>Sarmento</surname><given-names>S</given-names></name>, <name><surname>Sousa</surname><given-names>O</given-names></name>. <article-title>Assessment of clinically relevant dose distributions in pelvic IOERT using Gafchromic EBT3 films</article-title>. <source>Phys Med</source>. <year>2015</year>;<volume>31</volume>: <fpage>692</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmp.2015.05.013</pub-id>
<pub-id pub-id-type="pmid">26078013</pub-id></mixed-citation></ref><ref id="pone.0227155.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Calvo</surname><given-names>FA</given-names></name>, <name><surname>Sole</surname><given-names>CV</given-names></name>, <name><surname>Gonz&#x000e1;lez</surname><given-names>ME</given-names></name>, <name><surname>Tangco</surname><given-names>ED</given-names></name>, <name><surname>L&#x000f3;pez-Tarjuelo</surname><given-names>J</given-names></name>, <name><surname>Koubychine</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>Research opportunities in intraoperative radiation therapy: the next decade 2013&#x02013;2023</article-title>. <source>Clin Transl Oncol</source>
<year>2013</year>;<volume>15</volume>: <fpage>683</fpage>&#x02013;<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1007/s12094-013-1019-z</pub-id>
<pub-id pub-id-type="pmid">23463592</pub-id></mixed-citation></ref><ref id="pone.0227155.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Trifiletti</surname><given-names>DM</given-names></name>, <name><surname>Jones</surname><given-names>R</given-names></name>, <name><surname>Showalter</surname><given-names>SL</given-names></name>, <name><surname>Libby</surname><given-names>BB</given-names></name>, <name><surname>Brenin</surname><given-names>DR</given-names></name>, <name><surname>Schroen</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Techniques for intraoperative radiation therapy for early-stage breast carcinoma</article-title>. <source>Future Oncol</source>. <year>2015</year>;<volume>11</volume>: <fpage>1047</fpage>&#x02013;<lpage>1058</lpage>. <pub-id pub-id-type="doi">10.2217/fon.15.26</pub-id>
<pub-id pub-id-type="pmid">25804120</pub-id></mixed-citation></ref><ref id="pone.0227155.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Pascau</surname><given-names>J</given-names></name>, <name><surname>Santos-Miranda</surname><given-names>J</given-names></name>, <name><surname>Gonz&#x000e1;lez San-Segundo</surname><given-names>C</given-names></name>, <name><surname>Illana</surname><given-names>C</given-names></name>, <name><surname>Valdivieso</surname><given-names>M</given-names></name>, <name><surname>Garc&#x000ed;a-Vazquez</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Intraoperative imaging in IOERT sarcoma treatment: initial experience in two clinical cases</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2011</year>;<volume>81</volume>: <fpage>S90</fpage>
<pub-id pub-id-type="doi">10.1016/j.ijrobp.2011.06.184</pub-id></mixed-citation></ref><ref id="pone.0227155.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Low</surname><given-names>DA</given-names></name>, <name><surname>Harms</surname><given-names>WB</given-names></name>, <name><surname>Mutic</surname><given-names>S</given-names></name>, <name><surname>Purdy</surname><given-names>JA</given-names></name>. <article-title>A technique for the quantitative evaluation of dose distributions</article-title>. <source>Med Phys</source>. <year>1998</year>;<volume>25</volume>: <fpage>656</fpage>&#x02013;<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1118/1.598248</pub-id>
<pub-id pub-id-type="pmid">9608475</pub-id></mixed-citation></ref><ref id="pone.0227155.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Guerra</surname><given-names>P</given-names></name>, <name><surname>Ud&#x000ed;as</surname><given-names>JM</given-names></name>, <name><surname>Herranz</surname><given-names>E</given-names></name>, <name><surname>Santos-Miranda</surname><given-names>JA</given-names></name>, <name><surname>Herraiz</surname><given-names>JL</given-names></name>, <name><surname>Valdivieso</surname><given-names>MF</given-names></name>, <etal>et al</etal>
<article-title>Feasibility assessment of the interactive use of a Monte Carlo algorithm in treatment planning for intraoperative electron radiation therapy</article-title>. <source>Phys Med Biol</source>. <year>2014</year>;<volume>59</volume>: <fpage>7159</fpage>&#x02013;<lpage>7179</lpage>. <pub-id pub-id-type="doi">10.1088/0031-9155/59/23/7159</pub-id>
<pub-id pub-id-type="pmid">25365625</pub-id></mixed-citation></ref><ref id="pone.0227155.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Nemoto</surname><given-names>K</given-names></name>, <name><surname>Seiji</surname><given-names>K</given-names></name>, <name><surname>Sasaki</surname><given-names>K</given-names></name>, <name><surname>Kasamatsu</surname><given-names>N</given-names></name>, <name><surname>Fujishima</surname><given-names>T</given-names></name>, <name><surname>Ogawa</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>A novel support system for patient immobilization and transportation for daily computed tomographic localization of target prior to radiation therapy</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2003</year>;<volume>55</volume>: <fpage>1102</fpage>&#x02013;<lpage>1108</lpage>. <pub-id pub-id-type="doi">10.1016/s0360-3016(02)04513-3</pub-id>
<pub-id pub-id-type="pmid">12605990</pub-id></mixed-citation></ref><ref id="pone.0227155.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Pascau</surname><given-names>J</given-names></name>, <name><surname>Vaquero</surname><given-names>J</given-names></name>, <name><surname>Abella</surname><given-names>M</given-names></name>, <name><surname>Cacho</surname><given-names>R</given-names></name>, <name><surname>Lage</surname><given-names>E</given-names></name>, <name><surname>Desco</surname><given-names>M</given-names></name>. <article-title>Multimodality workstation for small animal image visualization and analysis</article-title>. <source>Mol Imaging Biol</source>. <year>2006</year>;<volume>8</volume>
<fpage>97</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-006-0031-x</pub-id></mixed-citation></ref><ref id="pone.0227155.ref015"><label>15</label><mixed-citation publication-type="book"><name><surname>Gonzalez</surname><given-names>RC</given-names></name>, <name><surname>Woods</surname><given-names>RE</given-names></name>. <source>Digital image processing</source>. <edition>3rd</edition> ed. <publisher-loc>Upper Saddle River</publisher-loc>: <publisher-name>Pearson/Prentice Hall</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="pone.0227155.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Pascau</surname><given-names>J</given-names></name>, <name><surname>Gispert</surname><given-names>JD</given-names></name>, <name><surname>Michaelides</surname><given-names>M</given-names></name>, <name><surname>Thanos</surname><given-names>PK</given-names></name>, <name><surname>Volkow</surname><given-names>ND</given-names></name>, <name><surname>Vaquero</surname><given-names>JJ</given-names></name>, <etal>et al</etal>
<article-title>Automated method for small-animal PET image registration with intrinsic validation</article-title>. <source>Mol Imaging Biol</source>. <year>2009</year>;<volume>11</volume>: <fpage>107</fpage>&#x02013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-008-0166-z</pub-id>
<pub-id pub-id-type="pmid">18670824</pub-id></mixed-citation></ref><ref id="pone.0227155.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Herranz</surname><given-names>E</given-names></name>, <name><surname>Herraiz</surname><given-names>JL</given-names></name>, <name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>P</given-names></name>, <name><surname>P&#x000e9;rez-Liva</surname><given-names>M</given-names></name>, <name><surname>Puebla</surname><given-names>R</given-names></name>, <name><surname>Cal-Gonz&#x000e1;lez</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Phase space determination from measured dose data for intraoperative electron radiation therapy</article-title>. <source>Phys Med Biol</source>. <year>2015</year>;<volume>60</volume>: <fpage>375</fpage>&#x02013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1088/0031-9155/60/1/375</pub-id>
<pub-id pub-id-type="pmid">25503853</pub-id></mixed-citation></ref><ref id="pone.0227155.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Garc&#x000ed;a-V&#x000e1;zquez</surname><given-names>V</given-names></name>, <name><surname>Marinetto</surname><given-names>E</given-names></name>, <name><surname>Guerra</surname><given-names>P</given-names></name>, <name><surname>Valdivieso-Casique</surname><given-names>MF</given-names></name>, <name><surname>Calvo</surname><given-names>F&#x000c1;</given-names></name>, <name><surname>Alvarado-V&#x000e1;squez</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Assessment of intraoperative 3D imaging alternatives for IOERT dose estimation</article-title>. <source>Z Med Phys</source>. <year>2017</year>;<volume>27</volume>: <fpage>218</fpage>&#x02013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1016/j.zemedi.2016.07.002</pub-id>
<pub-id pub-id-type="pmid">27567405</pub-id></mixed-citation></ref><ref id="pone.0227155.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Bresciani</surname><given-names>S</given-names></name>, <name><surname>Di Dia</surname><given-names>A</given-names></name>, <name><surname>Maggio</surname><given-names>A</given-names></name>, <name><surname>Cutaia</surname><given-names>C</given-names></name>, <name><surname>Miranti</surname><given-names>A</given-names></name>, <name><surname>Infusino</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Tomotherapy treatment plan quality assurance: the impact of applied criteria on passing rate in gamma index method</article-title>. <source>Med Phys</source>. <year>2013</year>;<volume>40</volume>: <fpage>121711</fpage>
<pub-id pub-id-type="doi">10.1118/1.4829515</pub-id>
<pub-id pub-id-type="pmid">24320497</pub-id></mixed-citation></ref><ref id="pone.0227155.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>L&#x000f3;pez-Tarjuelo</surname><given-names>J</given-names></name>, <name><surname>Bouch&#x000e9;-Babiloni</surname><given-names>A</given-names></name>, <name><surname>Santos-Serra</surname><given-names>A</given-names></name>, <name><surname>Morillo-Mac&#x000ed;as</surname><given-names>V</given-names></name>, <name><surname>Calvo</surname><given-names>FA</given-names></name>, <name><surname>Kubyshin</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Failure mode and effect analysis oriented to risk-reduction interventions in intraoperative electron radiation therapy: the specific impact of patient transportation, automation, and treatment planning availability</article-title>. <source>Radiother Oncol</source>. <year>2014</year>;<volume>113</volume>: <fpage>283</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/j.radonc.2014.11.012</pub-id>
<pub-id pub-id-type="pmid">25465728</pub-id></mixed-citation></ref><ref id="pone.0227155.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Hensley</surname><given-names>FW</given-names></name>. <article-title>Present state and issues in IORT physics</article-title>. <source>Radiat Oncol</source>. <year>2017</year>;<volume>12</volume>: <fpage>37</fpage>
<pub-id pub-id-type="doi">10.1186/s13014-016-0754-z</pub-id>
<pub-id pub-id-type="pmid">28193241</pub-id></mixed-citation></ref><ref id="pone.0227155.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Oshima</surname><given-names>T</given-names></name>, <name><surname>Aoyama</surname><given-names>Y</given-names></name>, <name><surname>Shimozato</surname><given-names>T</given-names></name>, <name><surname>Sawaki</surname><given-names>M</given-names></name>, <name><surname>Imai</surname><given-names>T</given-names></name>, <name><surname>Ito</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>An experimental attenuation plate to improve the dose distribution in intraoperative electron beam radiotherapy for breast cancer</article-title>. <source>Phys Med Biol</source>. <year>2009</year>;<volume>54</volume>: <fpage>3491</fpage>&#x02013;<lpage>3500</lpage>. <pub-id pub-id-type="doi">10.1088/0031-9155/54/11/014</pub-id>
<pub-id pub-id-type="pmid">19436105</pub-id></mixed-citation></ref><ref id="pone.0227155.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Rankin</surname><given-names>TM</given-names></name>, <name><surname>Giovinco</surname><given-names>NA</given-names></name>, <name><surname>Cucher</surname><given-names>DJ</given-names></name>, <name><surname>Watts</surname><given-names>G</given-names></name>, <name><surname>Hurwitz</surname><given-names>B</given-names></name>, <name><surname>Armstrong</surname><given-names>DG</given-names></name>. <article-title>Three-dimensional printing surgical instruments: are we there yet?</article-title>
<source>J Surg Res</source>. <year>2014</year>;<volume>189</volume>: <fpage>193</fpage>&#x02013;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2014.02.020</pub-id>
<pub-id pub-id-type="pmid">24721602</pub-id></mixed-citation></ref><ref id="pone.0227155.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Giantsoudi</surname><given-names>D</given-names></name>, <name><surname>De Man</surname><given-names>B</given-names></name>, <name><surname>Verburg</surname><given-names>J</given-names></name>, <name><surname>Trofimov</surname><given-names>A</given-names></name>, <name><surname>Jin</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Metal artifacts in computed tomography for radiation therapy planning: dosimetric effects and impact of metal artifact reduction</article-title>. <source>Phys Med Biol</source>. <year>2017</year>;<volume>62</volume>: <fpage>R49</fpage>&#x02013;<lpage>R80</lpage>. <pub-id pub-id-type="doi">10.1088/1361-6560/aa5293</pub-id>
<pub-id pub-id-type="pmid">28323641</pub-id></mixed-citation></ref><ref id="pone.0227155.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Costa</surname><given-names>F</given-names></name>, <name><surname>Sarmento</surname><given-names>S</given-names></name>, <name><surname>Gomes</surname><given-names>D</given-names></name>, <name><surname>Magalh&#x000e3;es</surname><given-names>H</given-names></name>, <name><surname>Arrais</surname><given-names>R</given-names></name>, <name><surname>Moreira</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>In vivo dosimetry using Gafchromic films during pelvic intraoperative electron radiation therapy (IOERT)</article-title>. <source>Br J Radiol</source>. <year>2016</year>;<volume>89</volume>: <fpage>20160193</fpage>
<pub-id pub-id-type="doi">10.1259/bjr.20160193</pub-id>
<pub-id pub-id-type="pmid">27188847</pub-id></mixed-citation></ref><ref id="pone.0227155.ref026"><label>26</label><mixed-citation publication-type="book"><name><surname>Khan</surname><given-names>FM</given-names></name>, <name><surname>Gibbons</surname><given-names>JP</given-names></name>. <chapter-title>Electron beam therapy</chapter-title> In: <name><surname>Pine</surname><given-names>JW</given-names><suffix>Jr</suffix></name>, <name><surname>Moyer</surname><given-names>E</given-names></name>, editors. <source>Khan's the physics of radiation therapy</source>. <publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name>; <year>2014</year> pp. <fpage>256</fpage>&#x02013;<lpage>308</lpage>.</mixed-citation></ref><ref id="pone.0227155.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Consorti</surname><given-names>R</given-names></name>, <name><surname>Petrucci</surname><given-names>A</given-names></name>, <name><surname>Fortunato</surname><given-names>F</given-names></name>, <name><surname>Soriani</surname><given-names>A</given-names></name>, <name><surname>Marzi</surname><given-names>S</given-names></name>, <name><surname>Iaccarino</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>In vivo dosimetry with MOSFETs: dosimetric characterization and first clinical results in intraoperative radiotherapy</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2005</year>;<volume>63</volume>: <fpage>952</fpage>&#x02013;<lpage>960</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijrobp.2005.02.049</pub-id>
<pub-id pub-id-type="pmid">16199324</pub-id></mixed-citation></ref><ref id="pone.0227155.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Soriani</surname><given-names>A</given-names></name>, <name><surname>Iaccarino</surname><given-names>G</given-names></name>, <name><surname>Felici</surname><given-names>G</given-names></name>, <name><surname>Ciccotelli</surname><given-names>A</given-names></name>, <name><surname>Pinnar&#x000f2;</surname><given-names>P</given-names></name>, <name><surname>Giordano</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Development and optimization of a beam shaper device for a mobile dedicated IOERT accelerator</article-title>. <source>Med Phys</source>. <year>2012</year>;<volume>39</volume>: <fpage>6080</fpage>&#x02013;<lpage>6089</lpage>. <pub-id pub-id-type="doi">10.1118/1.4749968</pub-id>
<pub-id pub-id-type="pmid">23039647</pub-id></mixed-citation></ref><ref id="pone.0227155.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Garc&#x000ed;a-V&#x000e1;zquez</surname><given-names>V</given-names></name>, <name><surname>Ses&#x000e9;-Lucio</surname><given-names>B</given-names></name>, <name><surname>Calvo</surname><given-names>FA</given-names></name>, <name><surname>Vaquero</surname><given-names>JJ</given-names></name>, <name><surname>Desco</surname><given-names>M</given-names></name>, <name><surname>Pascau</surname><given-names>J</given-names></name>. <article-title>Surface scanning for 3D dose calculation in intraoperative electron radiation therapy</article-title>. <source>Radiat Oncol</source>. <year>2018</year>;<volume>13</volume>: <fpage>243</fpage>
<pub-id pub-id-type="doi">10.1186/s13014-018-1181-0</pub-id>
<pub-id pub-id-type="pmid">30526626</pub-id></mixed-citation></ref></ref-list></back></article>